Merck & Co., Inc. MRK
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 479.40% | 68.51% | -243.10% | -48.78% | 30.68% |
| Total Depreciation and Amortization | 2.93% | 4.56% | -0.99% | 29.14% | 3.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -101.85% | -42.46% | 952.45% | 312.00% | -714.75% |
| Change in Net Operating Assets | -83.22% | 126.22% | 30.44% | -276.48% | 158.17% |
| Cash from Operations | 22.12% | 37.06% | 37.14% | -63.47% | 137.53% |
| Capital Expenditure | -16.46% | 9.89% | 4.07% | -4.66% | -29.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 89.22% | 33.45% | 12.58% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -69.02% | 357.50% | -249.21% | -117.90% | 11,833.33% |
| Cash from Investing | 76.45% | 45.13% | 8.85% | -3,857.95% | 63.25% |
| Total Debt Issued | -100.00% | 926.86% | -86.49% | 31.75% | -- |
| Total Debt Repaid | 100.00% | -426.75% | -56,900.00% | -100.00% | -- |
| Issuance of Common Stock | 474.42% | -72.61% | 234.04% | 235.71% | 16.67% |
| Repurchase of Common Stock | 13.74% | 13.39% | 30.19% | 5.37% | 1.64% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 2.10% | -1.85% | -4.31% | 0.64% | 2.21% |
| Other Financing Activities | 127.04% | -237.50% | -166.12% | 611.76% | 111.64% |
| Cash from Financing | -238.02% | 159.11% | -162.74% | 80.10% | 174.18% |
| Foreign Exchange rate Adjustments | -24.32% | -94.74% | -182.61% | 130.00% | -97.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 84.93% | 116.07% | -160.28% | -135.04% | 1,645.83% |